RAC 2.92% $1.94 race oncology ltd

MST valuation of RAC, page-279

  1. 2,460 Posts.
    lightbulb Created with Sketch. 354
    Thanks Dr T.

    Knowing that you use to be very dismissive about Australian ASX biotechs is interesting to know. I would assume many people in your position and your background would have a similar thinking... Probably why everyone invests in international biotechs instead and they're so bullish in comparison to Australian counterparts...
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.